Search

ProsTIC clinical trials currently open  PRIMARY2: Prospective multi‐centre Randomised trial of the additive diagnostic value of PSMA PET in men with negative/equivocal MRI in the diagnosis of... Read more

Our key publications  Latest Published Research Latest Published ResearchThe VIOLET Trial: First-in-human results of terbium-161... Read more

Our world leading research featured in the recent news Hofman's ASCO25 Highlights with GU Cast “Incredibly encouraging” first results of Terbium prostate cancer therapyRead the media releaseProsTIC Director... Read more

UroToday Interviews Terbium-161 vs Lutetium-177: Comparing Next-Gen Radioligands for Prostate Cancer PRINCE Trial Highlights Early Detection of Prostate Cancer Progression with PSMA PET-CT Comparing PSMA Ligands for Prostate... Read more

ProsTIC is the result of a vision from the Prostate Cancer Foundation. We aim to accelerate clinical trials and research in prostate cancer to facilitate better health outcomes for men. The additional support we receive from... Read more

2026 Preceptorship: Case by Case Theranostics - 3-5 SeptemberFollowing the outstanding success of the 2024 Preceptorship, which welcomed over 360 delegates from 26 countries and featured expert speakers from five continents, we... Read more